🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for SCD

Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease NCT07803055NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: blood sampling Sickle-cell Disease Registry of the GPOH NCT03327428n/a1 site📍 Heidelberg University Hospital Heidelberg A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM NCT06976606n/a6 sites📍 Redwood City📍 Baltimore📍 Columbia Lexeo Therapeutics Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa NCT05285917Phase 31 site📍 Luanda Brown University · Tests: Hydroxyurea Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors NCT07731191NA2 sites📍 Brescia📍 Brescia IRCCS Centro San Giovanni di Dio Fatebenefratelli · Tests: Digital solution for the prediction of the biological mechanisms of Alzheimer's disease through the analysis of ri… Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants NCT03937817n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function NCT07289061NA1 site📍 Thessaloniki Aristotle University Of Thessaloniki · Tests: Positive Psychology Intervention, Treatment as usual (TAU) Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease NCT06385886n/a9 sites📍 Birmingham📍 Phoenix📍 Oakland RTI International · Tests: Linkage Coordinator Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD NCT07770867NA7 sites📍 Daegu📍 Iksan📍 Seoul Neudive Inc. · Tests: NDTx-03, TAU A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease NCT06612268Phase 3175 sites📍 Birmingham📍 Mobile📍 Phoenix Novo Nordisk A/S · Tests: Etavopivat, Placebo The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease NCT06975865Phase 363 sites📍 Birmingham📍 Phoenix📍 Clovis Sanofi · Tests: Rilzabrutinib, Placebo Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudY NCT07137936n/a1 site📍 Beijing Beijing Anzhen Hospital Blood Sampling for Research Related to Sickle Cell Disease NCT00542230n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait NCT07083531n/a1 site📍 Farmington UConn Health · Tests: Healthy volunteers without SCT, Healthy volunteers with SCT Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease NCT07566494Phase 11 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: VAS-101 A Long-term Follow-up Study in Patients Who Received BEAM-101 NCT07373639n/a17 sites📍 Birmingham📍 Phoenix📍 Jacksonville Beam Therapeutics Inc. · Tests: Long-Term Follow-up Study of patients who received BEAM-101 A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM) NCT05885412Phase 13 sites📍 La Jolla📍 Durham📍 Philadelphia Rocket Pharmaceuticals Inc. · Tests: RP-A601 Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease NCT06941389n/a37 sites📍 Birmingham📍 Birmingham📍 Wilmington University of Rochester Natural History of Sickle Cell Disease NCT00081523n/a3 sites📍 Washington D.C.📍 Bethesda📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) CS-206 in Patients With Sickle Cell Disease NCT06565026EARLY Phase 11 site📍 Nanning CorrectSequence Therapeutics Co., Ltd · Tests: CS-206 Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study NCT07708714Phase 1, Phase 21 site📍 Kampala Children's Hospital Medical Center, Cincinnati · Tests: hydroxycarbamide Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation NCT05665608NA86 sites📍 Feldkirch📍 Graz📍 Innsbruck Charite University, Berlin, Germany · Tests: Implantable cardioverter-defibrillator (ICD), Optimal Medical Therapy (OMT) Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa mAnaging siCkle CELl disEase Through incReased AdopTion of hydroxyurEa in Nigeria NCT06318143NA1 site📍 Abuja New York University · Tests: TASSH, SIM Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax NCT05724121n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Personalized Digital Training for COGnitive FITness in Mild Cognitive Impairment NCT07286448NA2 sites📍 Modena📍 Milan Giovanna Zamboni · Tests: RICORDO, S.A.M.B.A. Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease NCT05099874NA1 site📍 Washington D.C. Children's National Research Institute · Tests: EndeavorRx Pressure Pain Tolerance in Relation to Balance and Strength in Children NCT06529874NA1 site📍 Giza Adly A Adam · Tests: Pressure pain tolerance measurement using Digital Pressure Algometer, Balance assessment using HUMAC balance system, Lo… Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease NCT06665997Phase 42 sites📍 Atlanta📍 Philadelphia University of Pennsylvania · Tests: Depot medroxyprogesterone acetate (DMPA) European Rare Blood Disorders Platform (ENROL) NCT06250595n/a1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Collection of clinical and laboratory data from EHR.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy